1
|
Fort DJ, Peake BF, Mathis MB, Leopold MA, Wolf JC, Weterings PJJM. Comparing the effects and potencies of perchlorate and nitrate on amphibian metamorphosis using a modified amphibian metamorphosis assay (AMA). J Appl Toxicol 2024; 44:1184-1197. [PMID: 38639310 DOI: 10.1002/jat.4611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Revised: 03/23/2024] [Accepted: 03/26/2024] [Indexed: 04/20/2024]
Abstract
A modified amphibian metamorphosis assay was performed in which Nieuwkoop and Faber (NF) stage 47 Xenopus laevis larvae were exposed to different concentrations of either perchlorate (ClO4 -) or nitrate (NO3 -) for 32 days. Larvae were exposed to 0.0 (control), 5, 25, 125, 625, and 3125 μg/L ClO4 -, or 0 (control), 23, 71, 217, 660, and 2000 mg/L NO3 -. The primary endpoints were survival, hind limb length (HLL), forelimb emergence and development, developmental stage (including time to NF stage 62 [MT62]), thyroid histopathology, wet weight, and snout-vent length (SVL). Developmental delay as evidenced by altered stage distribution and increased MT62, a higher degree of thyroid follicular cell hypertrophy, and an increase in the prevalence of follicular cell hyperplasia was observed at concentrations ≥125 μg/L ClO4 -. The no observed effect concentration (NOEC) for developmental endpoints was 25.0 μg/L ClO4 - and the NOEC for growth endpoints was 3125 μg/L ClO4 -. Exposure to nitrate did not adversely affect MT62, but a decreasing trend in stage distribution and median developmental stage at ≥217 mg/L NO3 - was observed. No histopathologic effects associated with nitrate exposure were observed. An increasing trend in SVL-normalized HLL was observed at 2000 mg/L NO3 -. Nitrate did not alter larval growth. The NOEC for developmental endpoints was 71 mg/L NO3 -, and 2000 mg/L NO3 - for growth endpoints. The present study provided additional evidence that the effects and potency of nitrate and perchlorate on metamorphosis and growth in X. laevis are considerably different.
Collapse
Affiliation(s)
- Douglas J Fort
- Fort Environmental Laboratories, Inc., Stillwater, Oklahoma, USA
| | | | - Michael B Mathis
- Fort Environmental Laboratories, Inc., Stillwater, Oklahoma, USA
| | | | - Jeffrey C Wolf
- Experimental Pathology Laboratories, Inc., Sterling, Virginia, USA
| | | |
Collapse
|
2
|
Lagadic L, Coady KK, Körner O, Miller TJ, Mingo V, Salinas ER, Sauer UG, Schopfer CR, Weltje L, Wheeler JR. Endocrine disruption assessment in aquatic vertebrates - Identification of substance-induced thyroid-mediated effect patterns. ENVIRONMENT INTERNATIONAL 2024; 191:108918. [PMID: 39270431 DOI: 10.1016/j.envint.2024.108918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Revised: 07/12/2024] [Accepted: 07/26/2024] [Indexed: 09/15/2024]
Abstract
According to the World Health Organisation and European Commission definitions, substances shall be considered as having endocrine disrupting properties if they show adverse effects, have endocrine activity and the adverse effects are a consequence of the endocrine activity (using a weight-of-evidence approach based on biological plausibility), unless the adverse effects are not relevant to humans or non-target organisms at the (sub)population level. To date, there is no decision logic on how to establish endocrine disruption via the thyroid modality in non-mammalian vertebrates. This paper describes an evidence-based decision logic compliant with the integrated approach to testing and assessment (IATA) concept, to identify thyroid-mediated effect patterns in aquatic vertebrates using amphibians as relevant models for thyroid disruption assessment. The decision logic includes existing test guidelines and methods and proposes detailed considerations on how to select relevant assays and interpret the findings. If the mammalian dataset used as the starting point indicates no thyroid concern, the Xenopus Eleutheroembryonic Thyroid Assay allows checking out thyroid-mediated activity in non-mammalian vertebrates, whereas the Amphibian Metamorphosis Assay or its extended, fixed termination stage variant inform on both thyroid-mediated activity and potentially population-relevant adversity. In evaluating findings, the response patterns of all assay endpoints are considered, including the direction of changes. Thyroid-mediated effect patterns identified at the individual level in the amphibian tests are followed by mode-of-action and population relevance assessments. Finally, all data are considered in an overarching weight-of-evidence evaluation. The logic has been designed generically and can be adapted, e.g. to accommodate fish tests once available for thyroid disruption assessments. It also ensures that all scientifically relevant information is considered, and that animal testing is minimised. The proposed decision logic can be included in regulatory assessments to facilitate the conclusion on whether substances meet the endocrine disruptor definition for the thyroid modality in non-mammalian vertebrates.
Collapse
Affiliation(s)
- Laurent Lagadic
- Bayer AG - R&D, Crop Science Division, Environmental Safety, Monheim, Germany.
| | | | - Oliver Körner
- ADAMA Deutschland GmbH, Environmental Safety, Köln, Germany
| | - Tara J Miller
- Syngenta, Jealott's Hill International Research Centre, Jealott's Hill, United Kingdom
| | | | - Edward R Salinas
- Bayer AG - R&D, Crop Science Division, Environmental Safety, Monheim, Germany
| | - Ursula G Sauer
- Scientific Consultancy - Animal Welfare, Neubiberg, Germany
| | | | - Lennart Weltje
- BASF SE, Agricultural Solutions - Ecotoxicology, Limburgerhof, Germany; Georg-August-University Göttingen, Division of Plant Pathology and Plant Protection, Göttingen, Germany
| | | |
Collapse
|
3
|
Fort DJ, Wolf JC, Langsch A, Fast B, Junker M, Otter R. Inefficacy of dietary test substance administration in Amphibian Metamorphosis Assay (AMA) studies. J Appl Toxicol 2024; 44:733-746. [PMID: 38151988 DOI: 10.1002/jat.4572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 11/30/2023] [Accepted: 12/04/2023] [Indexed: 12/29/2023]
Abstract
Traditionally, the Amphibian Metamorphosis Assay (AMA; OECD TG 231) is performed by exposing Xenopus laevis tadpoles to test substances dissolved in laboratory water. Recently, the use of dietary administration has been proposed to combat poorly soluble test substances in ecotoxicologically-based regulatory endocrine disruption (ED) studies, specifically the AMA warranting an investigation into the efficacy of dietary administration. An efficacy study comprised of two phases: 1) evaluation of the physical influence of the loading process via solvent and 10, 1, and 0.1 mg/l test substance or surrogate (sunflower oil, SFO) on the Sera® Micron Nature (SMN) diet, and 2) performance of a modified AMA in which Nieuwkoop and Faber (NF) stage 51 X. laevis larvae were exposed to dechlorinated tap water using one concentration of the SFO in the diet for 21 days, was performed. In phase 1, the addition of acetone or acetone with bis(2-propylheptyl) phthalate (DPHP) or SFO to SMN with subsequent solvent purge altered the diet reducing the density of the liquified diet and dietary pellet size following centrifugation indicative of alteration of the physical properties of the diet. Treatments used in the modified AMA were acetone alone and 0.1 mg/l SFO dissolved in acetone. These treatments were evaluated against an SMN benchmark using standard AMA endpoints. Both the acetone-treated SMN and 0.1 mg/l SFO-treated diets significantly reduced survival rates, 67 and 70% relative to the SMN benchmark (100%), decreased developmental stage distribution and snout-vent length-normalized hind limb length relative to the SMN benchmark, and slightly increased the prevalence and severity of thyroid follicular cell hypertrophy. Although the acetone-treated diets may have impacted the hypothalamo-pituitary-thyroid axis, clinical signs of gastrointestinal impaction and tail flexure were also observed in the acetone-treated diets, but not the SMN diet alone. Ultimately, test substance exposure via the diet in an AMA study can produce results that may confound data interpretation, which suggests that the traditional aqueous exposure route is generally more appropriate.
Collapse
Affiliation(s)
- Douglas J Fort
- Fort Environmental Laboratories, Stillwater, Oklahoma, USA
| | - Jeffrey C Wolf
- Experimental Pathology Laboratories, Inc., Sterling, Virginia, USA
| | | | | | | | | |
Collapse
|
4
|
Du Pasquier D, Salinier B, Coady KK, Jones A, Körner O, LaRocca J, Lemkine G, Robin-Duchesne B, Weltje L, Wheeler JR, Lagadic L. How the Xenopus eleutheroembryonic thyroid assay compares to the amphibian metamorphosis assay for detecting thyroid active chemicals. Regul Toxicol Pharmacol 2024; 149:105619. [PMID: 38614220 DOI: 10.1016/j.yrtph.2024.105619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Revised: 02/05/2024] [Accepted: 04/03/2024] [Indexed: 04/15/2024]
Abstract
The Xenopus Eleutheroembryonic Thyroid Assay (XETA) was recently published as an OECD Test Guideline for detecting chemicals acting on the thyroid axis. However, the OECD validation did not cover all mechanisms that can potentially be detected by the XETA. This study was therefore initiated to investigate and consolidate the applicability domain of the XETA regarding the following mechanisms: thyroid hormone receptor (THR) agonism, sodium-iodide symporter (NIS) inhibition, thyroperoxidase (TPO) inhibition, deiodinase (DIO) inhibition, glucocorticoid receptor (GR) agonism, and uridine 5'-diphospho-glucuronosyltransferase (UDPGT) induction. In total, 22 chemicals identified as thyroid-active or -inactive in Amphibian Metamorphosis Assays (AMAs) were tested using the XETA OECD Test Guideline. The comparison showed that both assays are highly concordant in identifying chemicals with mechanisms of action related to THR agonism, DIO inhibition, and GR agonism. They also consistently identified the UDPGT inducers as thyroid inactive. NIS inhibition, investigated using sodium perchlorate, was not detected in the XETA. TPO inhibition requires further mechanistic investigations as the reference chemicals tested resulted in opposing response directions in the XETA and AMA. This study contributes refining the applicability domain of the XETA, thereby helping to clarify the conditions where it can be used as an ethical alternative to the AMA.
Collapse
Affiliation(s)
- David Du Pasquier
- Laboratoire WatchFrog, 1 Rue Pierre Fontaine, 91000, Évry-Courcouronnes, France
| | - Benoît Salinier
- Laboratoire WatchFrog, 1 Rue Pierre Fontaine, 91000, Évry-Courcouronnes, France
| | - Katherine K Coady
- Bayer Crop Science, Environmental Safety, 700 Chesterfield Parkway West, Chesterfield, MO, USA
| | - Alan Jones
- ADAMA US, Environmental Safety, 3120 Highwoods Blvd., Raleigh, NC, 27604, USA
| | - Oliver Körner
- ADAMA, Environmental Safety, Edmund-Rumpler-Strasse 6, 51149, Cologne, Germany
| | - Jessica LaRocca
- Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, USA
| | - Gregory Lemkine
- Laboratoire WatchFrog, 1 Rue Pierre Fontaine, 91000, Évry-Courcouronnes, France
| | | | - Lennart Weltje
- BASF SE, Agricultural Solutions - Ecotoxicology, Speyerer Strasse 2, 67117, Limburgerhof, Germany
| | - James R Wheeler
- Corteva Agriscience, Zuid-Oostsingel 24D, 4611 BB, Bergen op Zoom, the Netherlands
| | - Laurent Lagadic
- Bayer AG R&D Crop Science, Alfred-Nobel-Strasse 50, 40789, Monheim am Rhein, Germany.
| |
Collapse
|
5
|
Wolf JC, Green JW, Mingo V, Marini JP, Schneider SZ, Fort DJ, Wheeler JR. Historical control histopathology data from amphibian metamorphosis assays and fathead minnow fish short term reproductive assays: A tool for data interpretation. AQUATIC TOXICOLOGY (AMSTERDAM, NETHERLANDS) 2024; 267:106811. [PMID: 38159458 DOI: 10.1016/j.aquatox.2023.106811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 12/17/2023] [Accepted: 12/19/2023] [Indexed: 01/03/2024]
Abstract
The Amphibian Metamorphosis Assay (AMA) is used to determine if a tested chemical has potential to impact the hypothalamic-pituitary-thyroid (HPT) axis of Xenopus laevis tadpoles, while the Fish Short Term Reproduction Assay (FSTRA) assesses potential effects on the hypothalamic-pituitary-gonadal (HPG) axis of fish such as the fathead minnow (Pimephales promelas). Several global regulatory programs routinely require these internationally validated tests be performed to determine the potential endocrine activity of chemicals. As such, they are conducted in accordance with standardized protocols and test criteria, which were originally developed more than a decade ago. Sizeable numbers of AMA and FSTRA studies have since been carried out, which allows for the mining of extensive historical control data (HCD). Such data are useful for investigating the existence of outlier results and aberrant control groups, identifying potential confounding variables, providing context for rare diagnoses, discriminating target from non-target effects, and for refining current testing paradigms. The present paper provides histopathology HCD from 55 AMA studies and 45 fathead minnow FSTRA studies, so that these data may become publicly available and thus aid in the interpretation of future study outcomes. Histopathology is a key endpoint in these assays, in which it is considered to be one of the most sensitive indicators of endocrine perturbation. In the current review, granular explorations of HCD data were used to identify background lesions, to assess the utility of particular diagnostic findings for distinguishing endocrine from non-endocrine effects, and to help determine if specific improvements to established regulatory guidance may be warranted. Knowledge gleaned from this investigation, supplemented by information from other recent studies, provided further context for the interpretation of AMA and FSTRA histopathology results. We recommend HCDs for the AMA and FSTRA be maintained to support the interpretation of study results.
Collapse
Affiliation(s)
- Jeffrey C Wolf
- Experimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA 20166, USA.
| | - John W Green
- John W Green Ecostatistical Consulting, LLC 372 Chickory Way, Newark, DE 19711, USA
| | - Valentin Mingo
- Corteva Agriscience, Riedenburger Str. 7, München 81677, Germany
| | | | | | - Douglas J Fort
- Fort Environmental Laboratories, Stillwater, OK 74074, USA
| | - James R Wheeler
- Corteva Agriscience, Zuid-Oostsingel 24D, Bergen op Zoom 4611 BB, the Netherlands
| |
Collapse
|
6
|
Marini JP, Wolf JC, Mingo V, Sayers LE, Jamieson SY, Wheeler JR. An Amphibian Metamorphosis Assay Dietary Restriction Study: Lessons for Data Interpretation. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY 2023; 42:1061-1074. [PMID: 36848316 DOI: 10.1002/etc.5596] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 01/03/2023] [Accepted: 02/22/2023] [Indexed: 06/18/2023]
Abstract
The amphibian metamorphosis assay (AMA) is a key in vivo endocrine screen to investigate chemicals with potential thyroid activity. The test guidelines and associated guidance consider that treatment-related effects on thyroid gland histomorphology automatically result in the assay being considered positive for thyroid activity, independent of the direction of change or conflicting results in the other biological endpoints. An AMA study was conducted with five different feeding rations equivalent to 50%, 30%, 20%, 10%, and 5% of the recommended feeding rate. Biological endpoints relating to growth and development, including thyroid gland histopathology, were evaluated, and the specificity of these endpoints for the determination of thyroid activity was assessed. There was no effect on survival or clinical signs of toxicity. Effects related to feed reduction generally occurred in a feeding ration-response manner and included reduced development stage; reduced body weight and body length metrics; decreased prevalence of thyroid follicular cell hyperplasia and hypertrophy, and the occurrence of thyroid atrophy; reduced liver vacuolation; and the occurrence of liver atrophy. The results indicate that treatment-related histopathological changes in the AMA can be induced by Non-chemical factors; therefore histopathological results are not necessarily diagnostically specific for chemically induced thyroid endocrine activity. Consequently, the interpretation of data from AMA studies should be adjusted accordingly. We recommend that the decision logic presented in the test guidelines and associated guidance be changed to reflect a requirement for directional agreement between the thyroid histopathology findings and the growth and developmental endpoints before it is concluded that a test substance has thyroid endocrine activity. Environ Toxicol Chem 2023;42:1061-1074. © 2023 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.
Collapse
Affiliation(s)
| | - Jeffrey C Wolf
- Experimental Pathology Laboratories, Sterling, Virginia, USA
| | | | | | | | | |
Collapse
|